The syndrome of partial mole.

Area of Science:

• Obstetrics and Gynecology
• Reproductive Endocrinology
• Oncology

Background:

• Gestational trophoblastic disease (GTD) encompasses a spectrum of placental abnormalities.
• Complete mole and partial mole represent distinct entities with varying clinical presentations and risks.

Purpose of the Study:

• To compare the clinical behavior, diagnostic challenges, and management outcomes of complete versus partial molar pregnancies.
• To highlight the necessity of human chorionic gonadotropin (hCG) monitoring for all molar pregnancies.

Main Methods:

• Retrospective analysis of 106 patients with complete mole and 35 patients with partial mole.
• Evaluation of clinical presentation, diagnostic difficulty, chemotherapy requirements, and treatment response.
• Assessment of the need for hCG monitoring in both groups.

Main Results:

• Complete moles presented with more pronounced clinical symptoms.
• Partial moles were more challenging to diagnose clinically.
• 20.7% of complete mole patients and 11.4% of partial mole patients required chemotherapy for persistent or metastatic disease.
• Partial moles demonstrated a more favorable response to chemotherapy.
• All patients required hCG monitoring due to the risk of malignant sequelae.

Conclusions:

• Clinical management and outcomes differ significantly between complete and partial moles.
• Early and accurate diagnosis is crucial, though challenging for partial moles.
• Vigilant hCG monitoring is essential for all patients with molar pregnancies to detect and manage malignant transformation.